SAN DIEGO, March 10, 2016 /PRNewswire/ -- OncoSec
Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company
developing DNA-based intratumoral cancer immunotherapies, announced
today that CEO and President Punit
Dhillon will present a corporate overview at the 28th Annual
ROTH Conference on Wednesday, March 16,
2016. The presentation is scheduled to begin at 8:00 AM PT at The Ritz Carlton, Orange County.
The 28th Annual ROTH Conference is one of the largest of its
kind in the US with over 500 participating companies and over 3,000
attendees. The conference will feature presentations from hundreds
of small and mid-cap public and private companies in a variety of
sectors including: healthcare, technology, business services, and
industrial growth. Over the course of the three-day event, there
will be several panel discussions, one-on-one meetings, and 10
concurrent tracks of company presentations. For more information,
please visit: http://www.roth.com/.
About OncoSec Medical Incorporated
OncoSec is a
biotechnology company developing DNA-based intratumoral
immunotherapies for the treatment of cancer. The Company's
investigational technology, ImmunoPulse™, is designed to enhance
the local delivery and uptake of DNA-based immune-targeting agents,
such as interleukin-12 (IL-12). In Phase I and II clinical trials,
OncoSec's lead program, ImmunoPulse™ IL-12, demonstrated a
favorable safety profile and evidence of anti-tumor activity in the
treatment of various skin cancers as well as the potential to
initiate a systemic immune response. ImmunoPulse™ IL-12 is
currently in Phase II development for several indications,
including metastatic melanoma and triple-negative breast cancer. In
addition to ImmunoPulse™ IL-12, the Company is also seeking to
identify and develop new immune-targeting agents for use with the
ImmunoPulse™ platform. For more information, please visit
www.oncosec.com.
Contact:
Mary
Marolla
OncoSec Medical Incorporated
855-662-6732
media@oncosec.com
Logo -
http://photos.prnewswire.com/prnh/20120905/LA68078LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/oncosec-to-present-at-28th-annual-roth-conference-300233901.html
SOURCE OncoSec Medical Incorporated